A rare bladder cancer - small cell carcinoma: review and update

Small cell carcinoma of the bladder (SCCB) is rare, highly aggressive and diagnosed mainly at advanced stages. Hematuria is the main symptom of this malignancy. The origin of the disease is unknown; however the multipotent stem cell theory applies best to this case. Histology and immunohistochemistry shows a tumour which is indistinguishable from small cell lung carcinoma (SCLC). Coexistence of SCCB with other types of carcinoma is common. The staging system used is the TNM-staging of bladder transitional cell carcinoma. The treatment is extrapolated from that of SCLC. However, many patients with SCCB undergo radical resection which is rarely performed in SCLC. Patients with surgically resectable disease (< or = cT1-4aN0M0) should be managed with multimodal therapy associating chemotherapy, surgery and/or radiotherapy. Neoadjuvant chemotherapy using four chemotherapy cycles followed by radical cystectomy is the most effective therapeutic sequence. Patients with unresectable disease (> or = cT4bN+M+) should be managed with palliative chemotherapy based on neuroendocrine type regimens comprising a platinum drug (cisplatin in fit patients). The prognosis of the disease is poor mainly in the case of pure small cell carcinoma. Other research programs are needed to improve the outcome of SCCB.

[1]  D. Bostwick,et al.  Small cell carcinoma of urinary bladder is differentiated from urothelial carcinoma by chromogranin expression, absence of CD44 variant 6 expression, a unique pattern of cytokeratin expression, and more intense gamma-enolase expression. , 1999, Histopathology.

[2]  M. Resnick,et al.  Small cell carcinoma of the genitourinary tract: an immunohistochemical, electron microscopic and clinicopathological study. , 1991, The Journal of urology.

[3]  L. Sullivan,et al.  Small cell carcinoma of the bladder , 1999, Cancer.

[4]  H. Moch,et al.  Chromosomal imbalances in small cell carcinomas of the urinary bladder , 1999, The Journal of pathology.

[5]  J. Mackey,et al.  Genitourinary small cell carcinoma: determination of clinical and therapeutic factors associated with survival. , 1998, The Journal of urology.

[6]  Ximing J. Yang,et al.  c-kit Expression in small cell carcinoma of the urinary bladder: prognostic and therapeutic implications , 2005, Modern Pathology.

[7]  G. González,et al.  Small Cell Carcinoma of the Urinary Bladder Treated with Chemotherapy and Radiotherapy: Results in Five Cases , 1999, European Urology.

[8]  A. Folpe,et al.  Thyroid Transcription Factor-1 Is Expressed in Extrapulmonary Small Cell Carcinomas but Not in Other Extrapulmonary Neuroendocrine Tumors , 2000, Modern Pathology.

[9]  J. Oesterling,et al.  Advanced small cell carcinoma of the bladder successful treatment with combined radical cystoprostatectomy and adjuvant methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy , 1990, Cancer.

[10]  S. Groshen,et al.  Radical cystectomy for primary neuroendocrine tumors of the bladder: the university of southern california experience. , 2005, The Journal of urology.

[11]  Ximing J. Yang,et al.  Thyroid transcription factor 1 expression in small cell carcinoma of the urinary bladder: an immunohistochemical profile of 44 cases. , 2005, Human pathology.

[12]  J. Droz,et al.  [The role of chemotherapy in the management of bladder cancer]. , 2011, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[13]  H. V. van Boven,et al.  Small cell carcinoma of bladder: a single-center prospective study of 25 cases treated in analogy to small cell lung cancer. , 2005, Urology.

[14]  Ximing J. Yang,et al.  Epidermal Growth Factor Receptor Protein Expression and Gene Amplification in Small Cell Carcinoma of the Urinary Bladder , 2007, Clinical Cancer Research.

[15]  D. Church,et al.  Clinical review - small cell carcinoma of the bladder. , 2006, Cancer treatment reviews.

[16]  H. Errihani,et al.  Rôle de la chimiothérapie dans la prise en charge du cancer de la vessie , 2011 .

[17]  Z. Arık,et al.  Small cell carcinoma of the urinary bladder with hypercalcemia , 2012, Medical Oncology.

[18]  J. Drabick,et al.  Significant activity of single agent vinorelbine against small-cell cancer of the bladder as second line chemotherapy: a case series and review of the literature. , 2012, Urologic oncology.

[19]  M. Aikawa,et al.  Neurosecretory granules in small cell invasive carcinoma of the urinary bladder , 1981, Cancer.

[20]  Y. Imamura,et al.  Small Cell Carcinoma of the Bladder , 2000, Acta Cytologica.

[21]  D. Grignon,et al.  Small cell carcinoma of the urinary bladder. A clinicopathologic analysis of 22 cases , 1992, Cancer.

[22]  H. Grossman,et al.  Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients , 2005 .

[23]  A. Lopez‐Beltran,et al.  Small Cell Carcinoma of the Urinary Bladder—Histogenesis, Genetics, Diagnosis, Biomarkers, Treatment, and Prognosis , 2007, Applied immunohistochemistry & molecular morphology : AIMM.

[24]  N. Choong,et al.  Small cell carcinoma of the urinary bladder , 2005, Cancer.

[25]  Liang Cheng,et al.  Small-cell carcinoma of the urinary bladder: diagnosis and management , 2006, Expert review of anticancer therapy.

[26]  N. Cook,et al.  Small cell carcinoma of the urinary bladder: a 15‐year retrospective review of treatment and survival in the Anglian Cancer Network , 2009, BJU international.

[27]  C. Meijer,et al.  Small cell carcinoma of the urinary bladder. A clinicopathologic, morphometric, immunohistochemical, and ultrastructural study of 18 cases , 1989, Cancer.

[28]  S. Horenblas,et al.  Symptomatic brain metastases from small-cell carcinoma of the urinary bladder: The Netherlands Cancer Institute experience and literature review. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[29]  Ximing J. Yang,et al.  Small cell carcinoma of the urinary bladder , 2004, Cancer.

[30]  J. Droz,et al.  Outcome of recurrent and metastatic small cell carcinoma of the bladder , 2009, BMC Urology.

[31]  J. Blay,et al.  Small cell cancer of the bladder: pathology, diagnosis, treatment and prognosis. , 2009, Bulletin du cancer.

[32]  Small cell cancer of the bladder: The Leon-Berard cancer centre experience , 2008, Indian journal of urology : IJU : journal of the Urological Society of India.

[33]  C. Moran,et al.  Small cell carcinoma of the bladder: a contemporary clinicopathological study of 51 cases , 2005, Histopathology.

[34]  D. Bostwick,et al.  Small cell carcinoma of urinary bladder is differentiated from urothelial carcinoma by chromogranin expression, absence of CD44 variant 6 expression, a unique pattern of cytokeratin expression, and more intense γ‐enolase expression , 1999 .

[35]  M. O'Brien,et al.  Treatment options for small cell lung cancer – do we have more choice? , 2010, British Journal of Cancer.

[36]  T. Terada.  Small cell carcinoma of the urinary bladder. , 2012, International journal of clinical and experimental pathology.

[37]  R. Millikan,et al.  Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: a retrospective review of the M. D. Anderson cancer experience. , 2004, The Journal of urology.

[38]  K. V. van Hoeven,et al.  Cytology of small cell carcinoma of the urinary bladder , 1996, Diagnostic cytopathology.

[39]  C. Dinney,et al.  The impact of variant histology on the outcome of bladder cancer treated with curative intent. , 2009, Urologic oncology.

[40]  S. Johansson,et al.  Primary small cell carcinoma of the bladder: a report of 25 cases. , 1995, The Journal of urology.

[41]  S. Horenblas,et al.  Long-term survival after sequential chemoradiation for limited disease small cell carcinoma of the bladder , 2009, World Journal of Urology.

[42]  N. Benjaafar,et al.  Neoadjuvant or adjuvant chemotherapy: what is the best treatment of muscle invasive bladder cancer? , 2011 .

[43]  R. Cowan,et al.  Small-cell carcinoma of the urinary bladder: 10-year experience. , 2004, Clinical oncology (Royal College of Radiologists (Great Britain)).

[44]  T. Terada.  Autopsy case of primary small cell carcinoma of the urinary bladder: KIT and PDGFRA expression and mutations , 2009, Pathology international.

[45]  P. Thall,et al.  Phase II clinical trial of neoadjuvant alternating doublet chemotherapy with ifosfamide/doxorubicin and etoposide/cisplatin in small-cell urothelial cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.